Home/Filings/4/0000950170-24-035460
4//SEC Filing

Shantharam Harish 4

Accession 0000950170-24-035460

CIK 0001042074other

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 5:03 PM ET

Size

10.2 KB

Accession

0000950170-24-035460

Insider Transaction Report

Form 4
Period: 2024-03-22
Shantharam Harish
Chief Financial Officer
Transactions
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2024-03-22360,0000 total
    Exercise: $8.76Exp: 2033-05-21Common Stock (360,000 underlying)
  • Disposition to Issuer

    Common Stock

    2024-03-2220,1250 total
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2024-03-2274,7500 total
    Exercise: $22.85Exp: 2034-01-23Common Stock (74,750 underlying)
Footnotes (2)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated as of February 11, 2024 (the "Merger Agreement"), by and among CymaBay Therapeutics, Inc. ("CymaBay"), Gilead Sciences, Inc., a Delaware corporation ("Gilead"), and Pacific Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Gilead ("Purchaser"), among other things, Purchaser merged with and into the Company (the "Merger"). Accordingly, each outstanding CymaBay restricted stock unit award was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of shares of CymaBay common stock subject to such restricted stock unit award and (ii) $32.50, less applicable withholding taxes.
  • [F2]Pursuant to the Merger Agreement, each outstanding CymaBay stock option, whether or not vested, was cancelled and converted into the right to receive a cash payment equal to the product of (a) the excess of (i) $32.50 over (ii) the per share exercise price of such stock option, and (b) the total number of shares of CymaBay common stock subject to such stock option immediately prior to the effective time of the Merger, less applicable withholding taxes. Any outstanding CymaBay stock option with an exercise price equal to or greater than $32.50 was canceled for no consideration.

Documents

1 file

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeother

Related Parties

1
  • filerCIK 0001976391

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 5:03 PM ET
Size
10.2 KB